Editorial: Inflammatory activity in symptomatic knee osteoarthritis: Not all inflammation is local

Arthritis and Rheumatology

Volumn 67, Issue 11, 2015, Pages 2797-2800

  Scanzello, Carla R ^a,b   Loeser, Richard F ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; MESSENGER RNA; PROSTAGLANDIN E SYNTHASE; HYDROXYICOSATETRAENOIC ACID; PROSTAGLANDIN E2;

ARACHIDONIC ACID METABOLISM; CELLULAR STRESS RESPONSE; CLINICAL TRIAL (TOPIC); HUMAN; INFLAMMATION; KNEE OSTEOARTHRITIS; LEUKOCYTE; MICROARRAY ANALYSIS; OSTEOARTHRITIS; PRIORITY JOURNAL; REVIEW; SYNOVIAL FLUID; BLOOD; FEMALE; KNEE; MALE; PATHOLOGY;

DINOPROSTONE; FEMALE; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; INFLAMMATION; KNEE JOINT; MALE; OSTEOARTHRITIS, KNEE;

EID: 84946091806     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39304     Document Type: Review

References (15)

1. Orlowsky EW, Kraus VB., The role of innate immunity in osteoarthritis: when our first line of defense goes on the offensive. J Rheumatol 2015; 42: 363-71.
2. Courties A, Gualillo O, Berenbaum F, Sellam J., Metabolic stress-induced joint inflammation and osteoarthritis. Osteoarthritis Cartilage 2015. E-pub ahead of print.
3. Van Spil WE, Welsing PM, Bierma-Zeinstra SM, Bijlsma JW, Roorda LD, Cats HA, et al., The ability of systemic biochemical markers to reflect presence, incidence, and progression of early-stage radiographic knee and hip osteoarthritis: data from CHECK. Osteoarthritis Cartilage 2015; 23: 1388-97.
4. Jin X, Beguerie JR, Zhang W, Blizzard L, Otahal P, Jones G, et al., Circulating C reactive protein in osteoarthritis: a systematic review and meta-analysis. Ann Rheum Dis 2015; 74: 703-10.
5. Sasaki E, Tsuda E, Yamamoto Y, Iwasaki K, Inoue R, Takahashi I, et al., Serum hyaluronan levels increase with the total number of osteoarthritic joints and are strongly associated with the presence of knee and finger osteoarthritis. Int Orthop 2013; 37: 925-30.
6. Attur M, Krasnokutsky S, Statnikov A, Samuels J, Li Z, Friese O, et al., Low-grade inflammation in symptomatic knee osteoarthritis: prognostic value of inflammatory plasma lipids and peripheral blood leukocyte biomarkers. Arthritis Rheumatol 2015; 67: 2905-15.
7. Attur M, Belitskaya-Levy I, Oh C, Krasnokutsky S, Greenberg J, Samuels J, et al., Increased interleukin-1β gene expression in peripheral blood leukocytes is associated with increased pain and predicts risk for progression of symptomatic knee osteoarthritis. Arthritis Rheum 2011; 63: 1908-17.
8. Kellgren JH, Lawrence JS., Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957; 16: 494-502.
9. Botha-Scheepers S, Watt I, Slagboom E, de Craen AJ, Meulenbelt I, Rosendaal FR, et al., Innate production of tumour necrosis factor α and interleukin 10 is associated with radiological progression of knee osteoarthritis. Ann Rheum Dis 2008; 67: 1165-9.
10. Goekoop RJ, Kloppenburg M, Kroon HM, Frolich M, Huizinga TW, Westendorp RG, et al., Low innate production of interleukin-1β and interleukin-6 is associated with the absence of osteoarthritis in old age. Osteoarthritis Cartilage 2010; 18: 942-7.
11. Pearle AD, Scanzello CR, George S, Mandl LA, DiCarlo EF, Peterson M, et al., Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis. Osteoarthritis Cartilage 2007; 15: 516-23.
12. Baker KR, Matthan NR, Lichtenstein AH, Niu J, Guermazi A, Roemer F, et al., Association of plasma n-6 and n-3 polyunsaturated fatty acids with synovitis in the knee: the MOST study. Osteoarthritis Cartilage 2012; 20: 382-7.
13. Daghestani HN, Pieper CF, Kraus VB., Soluble macrophage biomarkers indicate inflammatory phenotypes in patients with knee osteoarthritis. Arthritis Rheumatol 2015; 67: 956-65.
14. Snijder MB, van Dam RM, Visser M, Seidell JC., What aspects of body fat are particularly hazardous and how do we measure them? Int J Epidemiol 2006; 35: 83-92.
15. Hunter DJ, Nevitt M, Losina E, Kraus V., Biomarkers for osteoarthritis: current position and steps towards further validation. Best Pract Res Clin Rheumatol 2014; 28: 61-71.